DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Lambrechts D, Lenz HJ, de Haas S et al.
Markers of response for the antiangiogenic agent bevacizumab.
J Clin Oncol 2013;
31: 1219-1230
We do not assume any responsibility for the contents of the web pages of other providers.